Strategic Partnerships for Universities & Research Organisations. Dr John Turner Managing Director Flinders Technologies Pty Ltd [email protected] Strategic Partnerships for Universities and R&D Orgs. Significant at (1) national level & (2) enterprise level.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
However, an OECD (1994) study found :
“ Innovation performance depends not on how specific institutions perform (firms, R&D organizations, universities etc) but how they interact with each other……..”
First, the ‘national’ view :
We know Universities and R&D Organizations are sources of potentially valuable intellectual property and professional expertise
+ 15 Uni. based Science Parks
IP & Commercialization : they all bring essential elements togetherWIPO undertook a study into supporting Innovation Promotion Centers to assist developing countries
SUPPORT THROUGH & Commercialization : they all bring essential elements togetherPROFESSIONAL LINKAGES
Regional Innovation Promotion Centers
Universities, R&D expertise
Attorneys, Accountants, Business Consultants, International business, Management Training, Industry Assoc’s
Innovation Promotion Center
Project & Funds Manager
Innovation Investment Funds
(several industry-specific funds possible)
Various investors :
Banks, Venture Capital, Pension Funds, Business Angels, Specialist Technology Corporations, etc
Business Plan Implementation
Office support for ‘Start-ups’ co-located with the IPCs
Published Sept 2002 ISBN 0 95818 000 8
National Survey of Research Commercialisation, Year 2000
Australian Research Council
CSIRO & NHMRC
The study looked at performance comparisons (on a national basis) with Canada and the USA (for which data were available).
In my view, there are weaknesses in the study, but it provides a starting point for strategic assessments and initiatives at the national level.
Some results are on the following slides
Biological Science & Biotech. Australian universities & research organisations has been released
Physical, Chem. & Earth Sci.
Maths, Information & Coms Sci
Social, Behavioral & Economic Sci.
Humanities & Creative Arts
Engineering & Environmental Sci.
Health & Clinical Sci.
Licences – distribution by originating area of research
p35 National Survey of Research Commercialisation 2000
Topic 5The Role of Universities & R&D Organizations In the Innovation Cycle
(data removed – file too large to e-mail)
First the ‘national’ view
Second, the enterprise view – our experience :
Prior to the establishment of the company Flinders Technologies, Flinders University had only made $200 in royalty payments in 20 years.
Several attempts at commercializing IP had cost the University money and had not been successful.
The Vice Chancellor at the time (Prof. Keith Hancock) was an economist. Broadly speaking, he reasoned it was better to have a share in something successful than 100% of nothing. Thus, he agreed to a joint venture partnership with a Venture Capital company.
Enterprise Investments Ltd
Venture Capital Company
July 1987 50% 50%
January 1995 100% 0%
FlindersTechnologies Pty Ltd
To optimise the promotion and value of IP-based assets and the benefits from commercialization
Flinders University Australian universities & research organisations has been releasedShareholder Expectations
Enterprise Investments Ltd
Managing relationships can at times be difficult
Flinders Technologies Pty Ltd
Relations with the university are complex
Patent & Australian universities & research organisations has been releasedTrade Mark Attorneys
Professional peer groups
eg. LES, KCA, AVCAL
IPS (ANZ), WIPO
Scientific & Technical consultants
Alliances & Networks Throughout the World
Professional networks help us to achieve our
Technology Commercialization goals
Circles of Influence
- Technical value adding (eg technical feasibility)
- Commercial value adding ( eg patenting)
- Substantiate technical viability (eg 3rd party verification)
- Show commercial diligence (eg verification of IP, market)
- Enable value to be added & risk reduced
- Help avoid premature deal
- regular meetings with researchers : agreement on goals
- secure IP
- beware of compromising IP
Ions by Australian universities & research organisations has been released
Clinical DiagnosticFlinders Technologies Pty LtdSome of our projects
(eg FTA ‘DNA processing’; Ions by enzymes; New sunscreen; YourAmigo Pty Ltd )
(eg Flinders MediTech Pty Ltd & medical training devices; Re-Time Glasses & re-setting the biol. clock; Disease Profiling & new DNA process; Neugenesis Inc & recombinant DNA technology; MediMolecular Pty Ltd & new generation diagnostics)
Thanks forListening Again!